Tier 2 — strong
A 2-yr Randomized Controlled Trial on Creatine Supplementation during Exercise for Postmenopausal Bone Health
Med Sci Sports Exerc
2023
55(10):1750-1760
Bibliography
- PubMed
- PMID 37144634
- PubMed Central
- PMC10487398
- Funding
- Funded by the Canadian Institutes of Health Research and the Canada Foundation for Innovation.
- Competing interests
- Darren Candow disclosed industry-sponsored creatine research, creatine donations, travel support, AlzChem scientific-advisory-board service and expert-witness/consulting work.
Study snapshot
| Design | Two-year randomized placebo-controlled trial alongside resistance training and walking |
|---|---|
| Model | Human |
| Sample | 237 postmenopausal women, mean age about 59 years |
| Intervention | Creatine monohydrate 0.14 g/kg/day versus placebo plus resistance training 3 days/week and walking 6 days/week |
| Duration | 2 years |
| Endpoints | Femoral neck bone mineral density; Hip and lumbar-spine BMD; Proximal femur geometry; Muscle and functional measures |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- Best Creatine for Women: Evidence-Based Buying Guide for 2026How to choose the best creatine for women by form, dose, batch testing, menopause evidence, vegan diets and whether gendered formulas add...Read analysis
- Creatine and Menopause: Muscle, Strength, Bone and Brain EvidenceCreatine during and after menopause: the latest randomized evidence for lean mass and strength, uncertain bone effects, cognition research and practical dosing.Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
